Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis subject to the fulfilment of Conditions Precedent (CPs) and other terms and conditions as set out in the BTA.
According to primary filings and dispatches highlighted by NSE India, the latest move impacts key counters including relevant market segments. Market analysts note that volume activity and corporate disclosures indicate significant retail and domestic institutional engagement with the development.
Traders are proceeding with cautious positioning as downside risks and profit-booking pressures are closely monitored across market segments. Risk management parameters suggest awaiting clear base-building signals before taking fresh directional exposure.
Investors and intraday participants are advised to monitor official exchange disclosures on BSE and NSE, alongside subsequent management commentary. ZeroLive will continue monitoring real-time order book developments, price action triggers, and regulatory updates as they unfold.